Miao Wang
Impact in
- Cancer Research top 1%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Biochemistry top 0.5%
- Eicosanoids and Hypertension Pharmacology
Papers in
-
- Circular RNAs in diseases 16
- RNA modifications and cancer 16
-
- Antiplatelet Therapy and Cardiovascular Diseases 13
- Blood Pressure and Hypertension Studies 12
- Co-authors
- Garret A. FitzGerald (18 shared papers)Xianlin Han (21 shared papers)Tilo Großer (2 shared papers)Ying Yu (2 shared papers)Emer M. Smyth (1 shared paper)Ellen Puré (4 shared papers)John A. Lawson (7 shared papers)Alex Y. Chang (4 shared papers)
- Journals
- Biochemical and Biophysical Research Communications (6 papers)Arteriosclerosis Thrombosis and Vascular Biology (5 papers)Circulation (5 papers)Oncotarget (5 papers)Analytical Chemistry (4 papers)
- Partner nations
- ChinaUnited StatesSweden
In The Last Decade
Miao Wang
389 papers receiving 10.4k citations
Miao Wang's Hit Papers
Peers
Comparison fields: 5 of 196
- Cancer Research 1.4k
- Biochemistry 624
- Pharmacology 1.1k
- Molecular Biology 4.2k
- Biomaterials 669
Countries citing papers authored by Miao Wang
This map shows the geographic impact of Miao Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miao Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miao Wang more than expected).
Fields of papers citing papers by Miao Wang
This network shows the impact of papers produced by Miao Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miao Wang. The network helps show where Miao Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Miao Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 407 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 413 | |
| 2 | Myricetin: A review of the most recent research Hit paper breakdown → | 2020 | 268 |
| 3 | 2013 | 236 | |
| 4 | 2014 | 215 | |
| 5 | 2015 | 212 | |
| 6 | 1994 | 212 | |
| 7 | 2006 | 168 | |
| 8 | 2012 | 167 | |
| 9 | 2005 | 166 | |
| 10 | 2007 | 146 | |
| 11 | 2019 | 133 | |
| 12 | 2010 | 128 | |
| 13 | 2020 | 125 | |
| 14 | 2004 | 125 | |
| 15 | 2018 | 124 | |
| 16 | 2008 | 114 | |
| 17 | 2015 | 108 | |
| 18 | 2015 | 105 | |
| 19 | 2013 | 102 | |
| 20 | 2020 | 100 |
About Miao Wang
Miao Wang is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine, Cancer Research, Pulmonary and Respiratory Medicine and Surgery, having authored 407 papers that have together received 10.6k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (27 papers), MicroRNA in disease regulation (24 papers), Inflammatory mediators and NSAID effects (21 papers), Circular RNAs in diseases (16 papers), RNA modifications and cancer (16 papers), Cancer, Lipids, and Metabolism (14 papers), Antiplatelet Therapy and Cardiovascular Diseases (13 papers) and Blood Pressure and Hypertension Studies (12 papers). The work is most often cited by research in Cancer Research (1.4k citations), Biochemistry (624 citations), Pharmacology (1.1k citations), Molecular Biology (4.2k citations) and Biomaterials (669 citations). Miao Wang has collaborated with scholars based in China, United States and Sweden. Frequent co-authors include Garret A. FitzGerald, Xianlin Han, Tilo Großer, Ying Yu, Emer M. Smyth, Ellen Puré, John A. Lawson, Alex Y. Chang, Zhixing Cao and Rowland H. Han. Their work appears in journals such as Biochemical and Biophysical Research Communications, Arteriosclerosis Thrombosis and Vascular Biology, Circulation, Oncotarget and Analytical Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.